Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
01/11/2001 | DE19931709A1 Neue tetracyclische Acetale Novel tetracyclic acetals |
01/11/2001 | DE19931116A1 Verfahren zur Herstellung von Phenethylaminen und neue chemische Verbindungen Process for the preparation of novel chemical compounds and phenethylamines |
01/11/2001 | CA2377932A1 Control of gene expression in eukaryotic cells |
01/10/2001 | EP1067126A2 Tetracyclic acetals |
01/10/2001 | EP1067113A2 Process for the preparation of phenethylamines and intermediates therefor |
01/10/2001 | EP1066277A1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
01/10/2001 | EP1066276A1 Process for the synthesis of hiv protease inhibitors |
01/10/2001 | EP1066272A1 Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation |
01/10/2001 | EP1066258A1 Aryl phenyl substituted cyclic ketoenols |
01/10/2001 | EP1066251A1 Method for the production of 1,3-disubstituted 2-nitroguanidines |
01/10/2001 | EP0944310A4 Stabilized ascorbyl compositions |
01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
01/10/2001 | CN1279678A Method for producing phthalides |
01/10/2001 | CN1060477C 1-isopropyl-4-methyl bicyclic [2,2,2] octane-2,3-diacid anhydride and producing process thereof |
01/09/2001 | US6172261 Biosynthesis using chain extension |
01/09/2001 | US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same |
01/09/2001 | US6172109 Side effect reduction; administering topically |
01/09/2001 | US6172104 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
01/09/2001 | US6172103 Treating bone disorders, osteoporosis, and arthritis |
01/09/2001 | US6172099 Tricyclic compounds having saturated rings and medicinal compositions containing the same |
01/09/2001 | US6172085 Cyclic ether compounds as sodium channel modulators |
01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
01/09/2001 | US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
01/09/2001 | CA2117483C [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
01/09/2001 | CA2111854C Orally active antiviral compounds |
01/04/2001 | WO2001001135A1 Enzyme inhibition immunoassay |
01/04/2001 | WO2001000623A1 Method of producing nitroguanidine- and nitroenamine derivatives |
01/04/2001 | WO2001000607A1 Cyclohexenone derivatives of bicyclic benzoic acids as herbicides |
01/04/2001 | WO2001000581A1 Ligands based on chiral 2-amino-2'-hydroxy-1,1'-binaphthyl and related frameworks for asymmetric catalysis |
01/04/2001 | WO2001000579A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY |
01/04/2001 | WO2001000575A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
01/04/2001 | WO2001000561A1 Aromatic esters for marking or tagging organic products |
01/04/2001 | WO2001000229A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
01/04/2001 | WO2001000206A1 Vla-4 inhibitor compounds |
01/04/2001 | WO2000020358B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
01/04/2001 | DE19930075A1 Neue Amino- und Amidosulfonamide als antivirale Mittel New amino and Amidosulfonamide as antiviral agents |
01/04/2001 | DE19928550A1 Treatment of waste from the industrial manufacture of phthalic acid anhydride comprises contacting with an aliphatic alcohol component |
01/04/2001 | CA2369308A1 Vla-4 inhibitor compounds |
01/04/2001 | CA2369145A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
01/03/2001 | EP1065209A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them |
01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
01/03/2001 | EP1064255A1 A process for the manufacture of (2s,2'r,3'r)-2-(2,3-dicarboxylcyclopropyl)-glycine |
01/03/2001 | EP1063984A1 Inflammatory cell inhibitors |
01/03/2001 | EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
01/03/2001 | CN1278793A Sulfonyl derivatives |
01/03/2001 | CN1060165C Crowndaisy chrysantheins compound |
01/03/2001 | CN1060160C Method for refining carbamates compound |
01/02/2001 | US6169189 Process for preparing tetrahydrofuran from dialkoxybutenes |
01/02/2001 | US6169188 Treating cyclooxygenase-2 mediated diseases |
01/02/2001 | US6169187 Process for recovery of ascorbic acid |
01/02/2001 | US6169085 A viricide for preventing and treating retroviral infection or the spread of a retrovirus, inhibiting replication of a retrovirus and treating aids |
01/02/2001 | US6169075 Antitumor agent inhibiting the proliferation of a range of rapidly dividing tumour cells like melanoma and/or lymphoma cells |
01/02/2001 | CA2174034C Novel tricyclic amides, processes for their preparation and the pharmaceutical compositions which contain them |
01/02/2001 | CA2161662C Process for preparing intermediates for the synthesis of antifungal agent |
01/02/2001 | CA2009604C Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom |
12/28/2000 | WO2000078743A2 Preparation and use of gamma-butyrolactones as cross-linking agents |
12/28/2000 | WO2000078708A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
12/28/2000 | WO2000048466A3 Protease inhibitors that overcome drug resistance |
12/28/2000 | WO2000044379B1 Methods for restoring and/or enhancing accommodation in pseudo phakia |
12/28/2000 | DE19929259A1 New cyclohexanone derivatives of bicyclic benzoic acids useful as herbicides |
12/28/2000 | CA2375356A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
12/28/2000 | CA2368846A1 Preparation and use of gamma-butyrolactones as cross-linking agents |
12/27/2000 | EP1063224A1 Continuous hydrogenation process |
12/27/2000 | EP1063223A1 Polyenepolycarboxylic acids, derivatives thereof with respect to carboxyl groups, or salts of these |
12/27/2000 | EP1063222A1 Process for producing phthalic anhydride |
12/27/2000 | EP1061912A1 Phenanthrofuran derivatives |
12/27/2000 | EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
12/27/2000 | CN1278256A Ureido and thioureido derivatives of 4-amino-2-(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents |
12/27/2000 | CN1278244A Dipeptide nitriles |
12/27/2000 | CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same |
12/26/2000 | US6166226 Synthesis of aryl ethers |
12/26/2000 | US6166074 Pharmaceutical compositions |
12/26/2000 | US6166070 Kodaistatins A, B, C and D, a process for their production and their use |
12/26/2000 | US6166069 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
12/26/2000 | US6166064 Antiinflammatory agents; antiarthritic agents |
12/26/2000 | US6166028 Diaminopuridine-containing thiourea inhibitors of herpes viruses |
12/26/2000 | US6166013 For modulating the glucocorticoid receptor in a mammal |
12/26/2000 | US6166006 Having antagonistic activity on mcp-1 (monocyte chemoattractant protein-1) receptor; antiinflammatory agents |
12/26/2000 | US6164282 Methods for restoring and/or enhancing accommodation in pseudo phakia |
12/26/2000 | CA2207409C Novel processes for preparing ranitidine |
12/26/2000 | CA2150671C Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
12/25/2000 | CA2475401A1 Method for the preparation of citalopram |
12/23/2000 | CA2311996A1 Continuous hydrogenation process |
12/21/2000 | WO2000077007A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
12/21/2000 | WO2000076991A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
12/21/2000 | WO2000076990A1 New compounds |
12/21/2000 | WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors |
12/21/2000 | WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
12/21/2000 | WO2000076496A1 Tumor tissue accumulation enhancers for drugs |
12/21/2000 | WO2000053597A3 Benzofuran-2-ones as colorants for organic materials |
12/21/2000 | WO2000053581A3 Heterocyclic compounds having antitumor activity |
12/21/2000 | WO2000051993A3 Dihetero-substituted metalloprotease inhibitors |
12/21/2000 | DE19927912A1 Catalytic preparation of cyclic and/or polymer compounds by educt metathesis is performed in the presence of one or more heterogeneous catalysts and ionic liquids |
12/21/2000 | CA2375867A1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them |
12/21/2000 | CA2374627A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
12/21/2000 | CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors |
12/21/2000 | CA2340375A1 Agent for enhancing accumulation of drugs in tumor tissues |
12/20/2000 | EP1060175A2 Tryptase inhibitors |
12/20/2000 | EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents |